CVS Health Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
CVS Health (CVS) PT Raised to $100 at RBC Capital
November 7, 2018 7:11 AM ESTRBC Capital analyst George Hill raised the price target on CVS Health (NYSE: CVS) to $100.00 (from $99.00) while maintaining a Outperform rating.
... MoreCVS Health (CVS) Tops Q3 EPS by 2c
November 6, 2018 6:56 AM ESTCVS Health (NYSE: CVS) reported Q3 EPS of $1.73, $0.02 better than the analyst estimate of $1.71. Revenue for the quarter came in at $47.3 billion versus the consensus estimate of $47.2 billion.
GUIDANCE:
CVS Health sees FY2018 EPS of $6.98-$7.08, versus the consensus of... More
